ART begins SoftScan study in western Canada

AuntMinnie.com staff writers
Nov 23, 2005

Optical molecular imaging developer ART Advanced Research Technologies is beginning trials of its SoftScan optical breast system in western Canada.

The study, performed in collaboration with Central Alberta Medical Imaging Services (CAMIS) of Red Deer, Alberta, is part of the Saint-Laurent, Quebec-based firm's North American study of SoftScan.

By AuntMinnie.com staff writers
November 24, 2005

Related Reading

ART sales increase in Q3, November 3, 2005

ART launches clinical study, October 24, 2005

SoftScan trial under way, October 7, 2005

ART names Khayat as VP, September 8, 2005

ART cites equivalency with mammo, August 26, 2005

Copyright © 2005 AuntMinnie.com

Latest in Industry News
Blue Seal Mobile Installation Rsna2024
Calif. congressman seeks funding for mobile cancer screening units
December 20, 2024
Capitol Hill2
Women's lung cancer research bill inches forward
December 20, 2024
Ny Highlighted
New York radiologists fight legislation that would expand liability networks
December 20, 2024
Cms
CMS invites feedback on two MIPS value pathways
December 20, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2005 10 13 22 37 30 706
Market Analysis
AuntMinnie's IMV MarketStat #37: Types of images used in radiation therapy treatment plans
Wmv Icon
Industry News
Flute
2005 08 04 09 57 12 706
Market Analysis
AuntMinnie's IMV MarketStat #36: Transmission of echo images
More in Industry News
Calif. congressman seeks funding for mobile cancer screening units
By AuntMinnie.com staff writers
The bill angles for federal grants, contracts, and cooperative agreements for new mobile cancer screening units.
December 20, 2024
Blue Seal Mobile Installation Rsna2024
Women's lung cancer research bill inches forward
By AuntMinnie.com staff writers
The ACR is lauding the progress of HR 4534, the Women and Lung Cancer Research and Preventive Services Act of 2024.
December 20, 2024
Capitol Hill2
New York radiologists fight legislation that would expand liability networks
By AuntMinnie.com staff writers
The New York governor has vetoed past legislation due to its broad implications.
December 20, 2024
Ny Highlighted
CMS invites feedback on two MIPS value pathways
By AuntMinnie.com staff writers
The CMS has asked for comments from the radiology community in relation to its proposed diagnostic radiology and interventional radiology MIPS Value Pathways.
December 20, 2024
Cms
50-year veteran radiologist offers advice to young doctors
By AuntMinnie.com staff writers
Joe Tullis, MD, of Baxter Health reflects on his half-century in practice.
December 20, 2024
Tullis Thumbnail
ABII appoints new board of trustees member
By AuntMinnie.com staff writers
The American Board of Imaging Informatics (ABII) is appointing Tom Kern to its board of trustees.
December 19, 2024
Business Man Handshake 400
Shuttle enters agreement with UCSF to develop PSMA ligand
By AuntMinnie.com staff writers
Shuttle Pharmaceuticals Holdings has entered a research agreement with UCSF to develop Shuttle's ligand to the PSMA as a theranostic molecule.
December 19, 2024
Prostate Cancer 3 D Rendering 400 (1) (1)
ASRT reports enrollment increases in radiologic technologist programs
By AuntMinnie.com staff writers
The ASRT has published results from its 2024 enrollment snapshot, showing that the number of new students enrolled increased compared with 2023.
December 19, 2024
Student Doctor Laptop Test 400
MGMA weighs in on proposed CR from Congress
By AuntMinnie.com staff writers
The Medical Group Management Association (MGMA) is calling a proposed continuing resolution from Congress "a mixed bag" in addressing healthcare concerns.
December 18, 2024
Capitol Hill Government
FDA recalls Hologic's BioZorb markers
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has issued a recall of Hologic’s BioZorb 3D radiographic markers, with 252 injuries reported to date.
December 18, 2024
Fda
Varian secures FDA clearance for latest RapidArc technology
By AuntMinnie.com staff writers
Varian has received clearance from the U.S. Food and Drug Administration (FDA) to sell the latest version of its radiotherapy technology, RapidArc Dynamic.
December 18, 2024
Varian2
Radpair, deepc partner on AI platforms
By AuntMinnie.com staff writers
Radpair and deepc have entered a partnership in which deepc will act as Radpair's exclusive channel partner for AI platforms.
December 17, 2024
Artificial Intelligence Ai 400
Page 1 of 3510
Next Page